29.03.2017 23:10:00
|
Reynolds, State Officials and CVS Health Announce Availability of Naloxone at All CVS Pharmacy Locations in Iowa
DES MOINES, Iowa, March 29, 2017 /PRNewswire/ -- Today, CVS Health officials (NYSE: CVS) joined Iowa Lt. Gov. Kim Reynolds, Department of Public Health Director Gerd Clabaugh and Office of Drug Control Policy Director Steve Lukan in announcing the availability of the opioid overdose-reversal medicine naloxone without a prescription at all CVS Pharmacy locations in Iowa. CVS Health has established a standing order with physicians in Iowa that allows CVS Pharmacy to expand access to the medication in the state.
"Naloxone is a safe and effective antidote to opioid overdoses and by expanding access to this medication in our Iowa pharmacies by the use of a physician's standing order for patients without a prescription, we can help save lives," said Tom Davis, RPh, Vice President of Pharmacy Professional Practices at CVS Pharmacy. "We support expanding naloxone availability to give more people a chance to get the help they need for recovery and we applaud the State of Iowa for their leadership in the fight against drug abuse and addiction."
"Thanks to action we have taken in Iowa, first responders, family members, and others can now obtain and administer Naloxone more easily," said Reynolds. "I want to thank CVS Health for partnering in our multi-faceted approach to combat the opioid epidemic that has affected many Iowans. We need to continue to work together to prevent, treat and respond to this epidemic."
Today's naloxone announcement builds on CVS Health's longstanding commitment to helping communities address and prevent drug abuse. CVS Health has also joined with the Partnership for Drug-Free Kids to create the Medication Disposal for Safer Communities Program, which donates disposal units to local police departments, providing a safe and environmentally friendly way to dispose of unwanted medication. Police departments in Iowa can apply to receive a drug collection unit at www.cvs.com/safercommunities.
Additionally, CVS Health has launched digital resources on its website CVS.com that give patients and families a single destination to learn more about drug abuse prevention. And, in 2015, CVS Health launched a community outreach program called Pharmacists Teach, which brings local pharmacists to high school health classes to talk to students about the dangers of drug abuse. More than 200,000 students have already taken part in the program. High school teachers and administrators in Iowa can learn more about bringing Pharmacists Teach to their school at www.CVSHealth.com.
With the addition of Iowa, CVS Pharmacy now dispenses naloxone to patients without an individual prescription in these 41 states: Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Kentucky, Louisiana, Maryland, Massachusetts, Minnesota, Mississippi, Missouri, Montana, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oregon, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia and Wisconsin.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/reynolds-state-officials-and-cvs-health-announce-availability-of-naloxone-at-all-cvs-pharmacy-locations-in-iowa-300431413.html
SOURCE CVS Health
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu CVS Health Corpmehr Nachrichten
29.11.24 |
S&P 500-Papier CVS Health-Aktie: So viel Verlust wäre bei einem Investment in CVS Health von vor 10 Jahren angefallen (finanzen.at) | |
22.11.24 |
S&P 500-Wert CVS Health-Aktie: So viel Verlust hätte ein Investment in CVS Health von vor 5 Jahren bedeutet (finanzen.at) | |
18.11.24 |
Börse New York: S&P 500 verbucht am Nachmittag Gewinne (finanzen.at) | |
18.11.24 |
Börse New York: mittags Gewinne im S&P 500 (finanzen.at) | |
18.11.24 |
Activist investor Glenview secures 4 board seats at CVS Health (Financial Times) | |
15.11.24 |
S&P 500-Titel CVS Health-Aktie: So viel Verlust hätte eine CVS Health-Investition von vor 3 Jahren eingebracht (finanzen.at) | |
08.11.24 |
S&P 500-Papier CVS Health-Aktie: So viel Verlust hätte ein CVS Health-Investment von vor einem Jahr eingebracht (finanzen.at) | |
07.11.24 |
Handel in New York: Anleger lassen S&P 500 zum Ende des Donnerstagshandels steigen (finanzen.at) |